We are live on ! Find out more
HURA icon

TuHURA Biosciences
HURA

2 hedge funds and large institutions have $626K invested in TuHURA Biosciences in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0.07% less ownership

Funds ownership: 1.48% → 1.41% (-0.07%)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $3K

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Hartford Financial Management
Hartford Financial Management
Connecticut
-$1K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$1K
3
UBS Group
UBS Group
Switzerland
-$1K

HURA Hedge Fund Activity: Q1 2017 in Review

2 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2017, worth a combined $626K — up 26% from $498K a quarter earlier.

Fund positioning in HURA was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Hartford Financial Management, cutting an estimated $1K.

  • 2 institutional investors held TuHURA Biosciences (HURA) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $626K of TuHURA Biosciences stock for Q1 2017, up 26% quarter-over-quarter.
  • 0 funds opened new TuHURA Biosciences positions in Q1 2017 and 0 closed out.
  • The largest TuHURA Biosciences seller in Q1 2017 was Hartford Financial Management, an estimated $1K sold.

Based on aggregated 13F filings for Q1 2017.